Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.15 USD | -1.42% | +2.18% | -6.19% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Evolution of the average Target Price on Supernus Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Supernus Pharmaceuticals, Inc.
Piper Sandler | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- SUPN Stock
- Consensus Supernus Pharmaceuticals, Inc.